MONTREAL, Aug. 31,
2023 /CNW/ - The Good Shroom Co Inc. (the
"Company" or "MUSH") provides an update on its
expansion activities.
The Company is set to expand on a variety of its brands with new
products launching in the near future in the provinces of
Quebec and Alberta. At present, it sells over 20 cannabis
products under its various brands, with 7 of those accounting for
the majority of cannabis sales. As a result, the company has
focused its efforts on expanding those categories and product types
in an effort to increase sales specifically through innovations in
the edible and hash infused joint categories as further explained
below.
Quebec
In early August 2023 the Company
received notice of conditional acceptance of a variety of new
product listings to be launched this fall. With several variables
and product details yet to be confirmed on each of those listings
it is expected that the Company will be launching 7 to 13 more
products in the months of October and November of this year (Q1
& Q2 fiscal year 2024). Those products include CBD capsules,
hash infused joints, dried cannabis flower and edibles. Hash
infused joints and edibles may potentially result in significantly
more sales whereas cannabis flower and CBD capsules may have lower
volumes but, nonetheless, could contribute to its expansion.
Furthermore, it believes that the CBD capsule market may become a
category with more overall growth as consumers become more familiar
with CBD.
The Company's "Joints Infusés d'Afghan Gold", which are
joints infused with it's popular Afghan Gold hash maintains its
popularity and, depending on the week, is usually in the top 3
selling products in the concentrates category in terms of weekly
units sold. * One of the potential new listings is a different
variation of this exact product. Three other potential new listings
are innovations based on this product where the hash is not mixed
with cannabis flower but instead a strip of hash is placed in the
center of the pre-rolled cannabis joint to allow for a more
aromatic smoke. The former may be the first of its type in
Canada at the time of the expected
launches.
OG Jerk, THC infused beef jerky, remains a top selling
product in the edibles category. * The edibles portion of the
conditional product approval includes at least 2 more similar
savory snack products.
Alberta
This fall the Company is expecting to launch THC infused beef
jerky and mixed nuts. Based on the success of the beef jerky in
Quebec, and its belief that the
edibles category is saturated with sweets the Company is attempting
to diversify the offering with a line of savory edibles for
Albertans. Furthermore, it may also be launching 2 pre-rolled
joints, one of which is hash infused and the other is a standard
pre-rolled joint. The Company is approaching the Alberta market with caution and will be
placing an important focus on these initial launches before
submitting more products. It has hired a cannabis sales team to
assist with initial load-in orders for a variety of key independent
cannabis retail accounts across the province in its attempt to
enter this market as effectively as possible.
The Company is presently working on fiscal year 2023 financial
statements which are due by the end of November 2023 but may be disclosed prior to that
date.
*
https://quebec.weedcrawler.ca/best_sellers
About the Company
MUSH operates a portfolio of brands which include cannabis and
beverage products. It exists to promote the use of functional
ingredients such as mushrooms and cannabis in consumer
products.
Neither TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
Cautionary Note Regarding Forward-Looking
Information
This press release contains statements which constitute
"forward-looking statements" and "forward-looking information"
within the meaning of applicable securities laws, including
statements regarding the plans, intentions, beliefs and current
expectations of the Corporation with respect to future business
activities and sales, including the anticipated orders to be placed
by the SQDC. Forward-looking statements are often identified
by the words "may", "would", "could", "should", "will", "intend",
"plan", "anticipate", "believe", "estimate", "expect" or similar
expressions. Investors are cautioned that forward-looking
statements are not based on historical facts but instead reflect
the Corporation's expectations, estimates or projections concerning
future results or events based on the opinions, assumptions and
estimates of management considered reasonable at the date the
statements are made. Although the Corporation believes that the
expectations reflected in such forward-looking statements are
reasonable, such statements involve risks and uncertainties, and
undue reliance should not be placed thereon, as unknown or
unpredictable factors could have material adverse effects on future
results, performance or achievements. Among the key factors that
could cause actual results to differ materially from those
projected are the following: market acceptance of the
Company's hash and other cannabis products, changes in the vendor's
business or strategy, changes in our supplier's operations and
pricing, expectations regarding competition and their pricing
strategy; maintaining in good standing all necessary regulatory
licenses and authorizations for its products; the benefits, safety,
efficacy, dosing and social acceptance of cannabis related products
and no material changes in the legal environment; changes in
applicable laws and regulations compliance with extensive
government regulation; operational risks related to and COVID-19 or
other pandemic and supply chain disruptions and shortages.
Should one or more of these risks or uncertainties materialize, or
should assumptions underlying the forward-looking statements prove
incorrect, actual results may vary materially from those described
herein as intended, planned, anticipated, believed, estimated or
expected. Although the Company has attempted to identify important
risks, uncertainties and factors which could cause actual results
to differ materially, there may be others that cause results not to
be as anticipated, estimated or intended and such changes could be
material. The Company does not intend, and do not assume any
obligation, to update the forward-looking statements except as
otherwise required by applicable law. Trading in the
securities of the Company should be considered highly
speculative.
SOURCE The Good Shroom Co Inc.